Arcadia Biosciences (RKDA) Short Interest Ratio & Short Volume → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free RKDA Stock Alerts $2.09 +0.19 (+10.00%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Arcadia Biosciences Short Interest DataCurrent Short Volume4,100 sharesPrevious Short Volume3,700 sharesChange Vs. Previous Month+10.81%Dollar Volume Sold Short$7,749.00Short Interest Ratio / Days to Cover0.2Last Record DateApril 15, 2024Outstanding Shares1,360,000 sharesFloat Size596,400 sharesShort Percent of Float0.69%Today's Trading Volume9,554 sharesAverage Trading Volume20,228 sharesToday's Volume Vs. Average47% Short Selling Arcadia Biosciences ? Sign up to receive the latest short interest report for Arcadia Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRKDA Short Interest Over TimeRKDA Days to Cover Over TimeRKDA Percentage of Float Shorted Over Time Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Arcadia Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20244,100 shares $7,749.00 +10.8%0.7%0.2 $1.89 3/31/20243,700 shares $8,177.00 No Change0.6%0.2 $2.21 3/15/20243,700 shares $9,435.00 -9.8%0.6%0.1 $2.55 2/29/20244,100 shares $11,685.00 +51.9%0.7%0.1 $2.85 2/15/20242,700 shares $7,965.00 +80.0%0.5%0.1 $2.95 1/31/20241,500 shares $3,585.00 -91.0%0.3%0 $2.39 Get the Latest News and Ratings for RKDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arcadia Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/202416,600 shares $43,990.00 +97.6%2.8%0.5 $2.65 12/31/20238,400 shares $26,292.00 -19.2%1.4%0.2 $3.13 12/15/202310,400 shares $30,368.00 +82.5%1.7%0.5 $2.92 11/30/20235,700 shares $16,530.00 +18.8%1.0%0.3 $2.90 11/15/20234,800 shares $14,784.00 -52.9%0.8%0.3 $3.08 10/31/202310,200 shares $34,968.66 +100.0%1.7%0.6 $3.43 10/15/20235,100 shares $16,014.00 -8.9%0.9%0.3 $3.14 9/30/20235,600 shares $18,760.00 +33.3%0.9%0.2 $3.35 9/15/20234,200 shares $15,414.00 +600.0%0.7%0.1 $3.67 8/31/2023600 shares $2,100.00 -87.2%0.1%0 $3.50 8/15/20234,700 shares $20,539.00 -57.7%0.8%0.1 $4.37 7/31/202311,100 shares $49,062.00 -33.1%1.9%0.3 $4.42 7/15/202316,600 shares $74,036.00 +44.4%2.8%0.3 $4.46 6/30/202311,500 shares $44,620.00 +29.2%1.9%0.3 $3.88 6/15/20238,900 shares $37,024.00 -29.9%1.5%0.3 $4.16 5/31/202312,700 shares $58,293.00 +2.4%2.2%0.4 $4.59 5/15/202312,400 shares $61,008.00 -69.8%2.1%0.1 $4.92 4/30/202341,000 shares $250,100.00 -1.9%6.9%0.3 $6.10 4/15/202341,800 shares $278,806.00 +1.0%7.1%0.3 $6.67 3/31/202341,400 shares $309,258.00 -42.8%7.1%0.3 $7.47 3/15/202372,400 shares $528,520.00 +2,684.6%12.3%0.5 $7.30 2/28/20232,600 shares $650.26 -97.5%0.4%0 $0.25 2/15/2023102,700 shares $27,729.00 +13.5%N/A0.4 $0.27 1/31/202390,500 shares $23,502.85 -23.1%N/A0.4 $0.26 1/15/2023117,700 shares $42,360.23 +16.3%N/A0.6 $0.36 12/30/2022101,200 shares $27,425.20 -63.2%N/A0.5 $0.27 12/15/2022274,900 shares $87,913.02 -38.1%N/A1.5 $0.32 11/30/2022443,800 shares $148,761.76 -28.7%N/A2.4 $0.34 11/15/2022622,500 shares $208,288.50 +83.6%N/A3.1 $0.33 10/31/2022339,000 shares $142,719.00 -10.9%N/A1.7 $0.42 10/15/2022380,400 shares $154,594.56 -6.7%N/A2.3 $0.41 9/30/2022407,800 shares $215,277.62 -3.0%N/A2.7 $0.53 9/15/2022420,200 shares $322,713.60 -12.0%N/A2.7 $0.77 8/31/2022477,500 shares $416,618.75 -10.1%N/A2.9 $0.87Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> RKDA Short Interest - Frequently Asked Questions What is Arcadia Biosciences' current short interest? Short interest is the volume of Arcadia Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 4,100 shares of RKDA short. 0.69% of Arcadia Biosciences' shares are currently sold short. Learn More on Arcadia Biosciences' current short interest. What is a good short interest percentage for Arcadia Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.69% of Arcadia Biosciences' floating shares are currently sold short. Is Arcadia Biosciences' short interest increasing or decreasing? Arcadia Biosciences saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 4,100 shares, an increase of 10.8% from the previous total of 3,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Arcadia Biosciences' float size? Arcadia Biosciences currently has issued a total of 1,360,000 shares. Some of Arcadia Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Arcadia Biosciences currently has a public float of 596,400 shares. How does Arcadia Biosciences' short interest compare to its competitors? 0.69% of Arcadia Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Arcadia Biosciences: SenesTech, Inc. (5.07%), YanGuFang International Group Co., Ltd. (0.09%), Evogene Ltd. (0.17%), China Green Agriculture, Inc. (0.77%), The Hain Celestial Group, Inc. (4.46%), Kaival Brands Innovations Group, Inc. (10.98%), Vintage Wine Estates, Inc. (6.96%), CVR Partners, LP (2.87%), Corteva, Inc. (1.37%), Colgate-Palmolive (1.15%), and Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Arcadia Biosciences stock? Short selling RKDA is an investing strategy that aims to generate trading profit from Arcadia Biosciences as its price is falling. RKDA shares are trading up $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Arcadia Biosciences? A short squeeze for Arcadia Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RKDA, which in turn drives the price of the stock up even further. How often is Arcadia Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RKDA, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: SenesTech Short Interest Data Stryve Foods Short Interest Data Westrock Coffee Short Interest Data Whole Earth Brands Short Interest Data YanGuFang International Group Short Interest Data Evogene Short Interest Data China Green Agriculture Short Interest Data The Hain Celestial Group Short Interest Data AgriFORCE Growing Systems Short Interest Data BTC Digital Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RKDA) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals